USPTO trademark

NUCLISAFE

Under examinationUSPTOWord markClass 5Class 10Class 42Class 44

"NUCLISAFE" is a word mark owned by Liquid Biopsy Research LLC, filed at the USPTO on October 27, 2026. It is under examination and covers classes 5, 10, 42 and 44.

Official USPTO record
NUCLISAFE trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
October 27, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50184331
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
4 classes
Ownership

Who owns NUCLISAFE

The owner and representative on file with the office.

Owner

Liquid Biopsy Research LLC

Charlestown, St. Kitts & Nevis

Representative

Connie L. Ellerbach

Fenwick & West LLP

Goods and services

What the mark covers

The products and services NUCLISAFE is filed for, grouped by Nice class.

  • Diagnostic preparations for medical use; Reagents for medical use, namely, reagents for stabilizing nucleic acids in biological specimens, specimen preservation reagents, reagents for RNA stabilization, molecular diagnostic reagents for RNA expression analysis, transcriptomic diagnostic reagents, messenger RNA (mRNA) testing reagents, liquid biopsy molecular diagnostic reagents, reagents for stabilizing DNA in biological specimens, DNA preservation reagents, nucleic acid stabilization reagents for simultaneous preservation of DNA and RNA, reagents for genomic DNA isolation and preservation, reagents for circulating cell-free DNA (cfDNA) stabilization, reagents for preservation of genomic, mitochondrial and microbial DNA, liquid biopsy reagents for DNA mutation analysis; Chemical reagents being nucleic acid preservation media for medical diagnostic use; Blood collection tubes sold filled with chemical reagents for stabilizing nucleic acid for medical diagnostic use; Blood collection tubes sold filled with reagents for stabilizing DNA and RNA for medical diagnostic use

  • Blood testing apparatus; Blood testing apparatus, namely, blood collecting tubes; Blood testing apparatus, namely, blood sampling tubes; Medical diagnostic apparatus for detecting gene alterations, tumors, and cancer; Diagnostic apparatus for medical purposes used in medical laboratories for testing mRNA; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical specimen collection devices in the nature of blood collection tubes for the collection of blood; Apparatus for taking blood samples; Apparatus for taking blood; Blood drawing apparatus; Medical instruments for measuring and displaying liquid biopsy diagnostics; Blood pretreatment apparatus and instruments; Blood component separation apparatus for medical purposes; Medical specimen collection devices in the nature of tubes for the collection and preservation of RNA; Medical blood specimen collection devices in the nature of tubes for the collection and stabilization of nucleic acids; Specimen collection devices in the nature of tubes for the collection and preservation of medical samples; Medical devices for obtaining body fluid samples, namely, saliva collection devices; Medical specimen collection devices in the nature of tubes for the collection and preservation of saliva; Medical specimen collection devices in the nature of kits consisting of swabs and glass tubes for the collection of saliva for molecular diagnostic testing; Medical specimen collection devices in the nature of tubes for the collection and preservation of genomic DNA, cell-free DNA (cfDNA), circulating tumor DNA (ctDNA) and microbial DNA; Medical specimen collection devices in the nature of saliva collection tubes for the collection and stabilization of DNA; Medical specimen collection devices nucleic acid stabilization kits consisting of needles, tubes, and swabs for the collection of blood, saliva and other biological specimens

  • Blood analysis for scientific research purposes; Genetic testing for scientific research purposes; Polymerase chain reaction (PCR) testing for scientific research purposes; Polymerase chain reaction (PCR) testing for medical research purposes; Medical research laboratories; Biological research in the field of bioinformatics and genomic bioinformatics; Scientific research, namely, genomic and transcriptomic data analysis, DNA mutation analysis, cell-free DNA (cfDNA) analysis, circulating tumor DNA (ctDNA) analysis, integrated DNA/RNA multi-omic analysis; Biochemical analysis services in the field of genomic sequencing

  • Collection and preservation of human blood; Collection and preservation of human saliva; Blood analysis services for diagnostic purposes provided by medical laboratories; Blood analysis services being medical analysis services for diagnostic treatment purposes provided by medical laboratories; Blood testing services being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical testing services, namely, molecular diagnostic testing services, liquid biopsy testing, RNA expression testing, molecular profiling, DNA-based molecular diagnostic testing, genomic testing, hereditary disease genetic testing, circulating tumor DNA (ctDNA) testing, cell-free DNA (cfDNA) testing, and pharmacogenomic testing; Molecular pathology services based on DNA and RNA biomarkers for medical diagnostic and treatment purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. New application entered
FAQ

About NUCLISAFE

Who owns the trademark "NUCLISAFE"?

The USPTO trademark "NUCLISAFE" (application 50184331) is owned by Liquid Biopsy Research LLC.

What is the status of "NUCLISAFE"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull NUCLISAFE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_01a1829f-46f9-70ab-9884-a262fcbbc86f
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a1829f-46f9-70ab-9884-a262fcbbc86f",
  "object": "trademark",
  "mark_text": "NUCLISAFE",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50184331",
  "filing_date": "2026-10-27",
  "nice_classes": [
    5,
    10,
    42,
    44
  ],
  "owners": [
    {
      "name": "Liquid Biopsy Research LLC",
      "entity_id": null
    }
  ]
}